Use of Targeted Therapies in Cancer Treatment - RAD175

Use of Targeted Therapies in Cancer Treatment

by Steven S. Bhimji, MD, PhD
RAD175
(4.5 / 0 ratings )

This course is credentialed for:
Radiologic Technology (0.75 CE Credit)

ONLINE
Price: $10.00
CE-PRO Price: $5.00

Summary:

During the past two decades, researchers have been focusing on therapies aimed at the striking of cancer cells at the molecular level. The goal of specific molecular targeted therapies for cancer is for the agent to act like a “magic bullet” that selectively targets only the cancer cells. As the understanding of cancer cell biology evolves, it is hoped that more therapies will be developed to target only certain components of the cancer cell and that therapies will be designed to have minimal or no effects on normal cells, which is distinct from present day chemotherapy and radiotherapy. One of the targets of the molecular-based therapies is the HER (ErbB) family of transmembrane receptor tyrosine kinases. The tyrosine kinase receptors are located on the cell surface and bind with a variety of drugs, hormones and neurotransmitters.

Objectives:

The goal of this targeted therapy for cancer continuing education program is to provide pharmacists and imaging technologists with adequate information about developments in targeted therapies for treatment of various cancers. After studying the material presented here, you will be able to:
  • Explain how targeted therapies have evolved and what protein molecules they interact with to arrest cancer growth
  • Discuss the approved target agents and their role in treatment of cancer
  • List the adverse effects of target agents used to treat cancers
 

 
Approval Information
 
This course is intended for an interprofessional audience, including pharmacists and imaging technologists.
 
Imaging technologists: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com/ and search for this topic title.
 
This activity is approved for Category A continuing education credit by the American Society of Radiologic Technologists (ASRT) for 9/4/2015 to 10/1/2018.
 
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.

Course Originally Released on: 1/7/2015
Date of Most Recent Review: 1/7/2015
Course Termination/Update Date: 10/1/2018

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

Sort By
LINDSEY K - lakeland, FL  ·  Nov 28, 2017
good material the questions were relatable
Was this review helpful?  0
 
catherine l - debary, FL  ·  Nov 16, 2017
great oncology info for health care workers
Was this review helpful?  0
 
KELLY R - LAWRENCEVILLE, GA  ·  Nov 10, 2017
Very insightful on the variations of therapies offered to pts
Was this review helpful?  0
 
Carla S - glendale, AZ  ·  Nov 10, 2017
interesting read on cancer treatment therapies
Was this review helpful?  0
 
ROBYN V - Devils Lake, ND  ·  Nov 08, 2017
interesting information i was unaware of
Was this review helpful?  0
 
  Page: of 10  
ONLINE
Price: $10.00
CE-PRO Price: $5.00